Comparing Dayvigo vs Belsomra
Dayvigo | Belsomra |
|
---|
Dayvigo (lemborexant) | Belsomra (suvorexant) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Insomnia. Dayvigo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Belsomra may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
More about Dayvigo (lemborexant) | More about Belsomra (suvorexant) | ||||||||||||||||
Generic Status | |||||||||||||||||
No lower-cost generic available |
No lower-cost generic available |
||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Dayvigo has an average rating of 4.9 out of 10 from a total of 255 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 50% reported a negative effect. |
Belsomra has an average rating of 3.7 out of 10 from a total of 535 ratings on Drugs.com. 26% of reviewers reported a positive effect, while 64% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: Dayvigo side effects in more detail. |
See also: Belsomra side effects in more detail. |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Dayvigo prices |
View all Belsomra prices |
||||||||||||||||
Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
19 hours |
12 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 425 drugs are known to interact with Dayvigo:
|
A total of 475 drugs are known to interact with Belsomra:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
December 20, 2019 |
August 13, 2014 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.